<\/span><\/h2>\n“The risks associated with stem cell therapy for stroke are generally low when performed in a reputable clinic, but can include infection at the injection site, temporary fever, and, in rare cases, an immune reaction to donor cells. Most side effects are mild and transient.”<\/p>\n
The procedure is minimally invasive, which significantly reduces the risks compared to more invasive surgical interventions. The most common side effects are minor and may include fatigue, headache, or nausea immediately following the infusion, which typically resolve within a day or two.<\/p>\n
The risk of an immune reaction is minimized by using mesenchymal stem cells, which have immunomodulatory properties, meaning they are less likely to be rejected by the recipient’s immune system. Clinics also perform thorough screening of donor cells to ensure their safety and viability. It’s important to discuss all potential risks with the medical team before undergoing treatment.<\/p>\n
<\/span>What is the success rate of stem cell therapy for stroke in Colombia?<\/strong><\/span><\/h2>\n“While success rates can vary depending on the individual patient and the severity of their stroke, many patients who undergo stem cell therapy for stroke in Colombia experience significant improvements in motor function, cognitive abilities, and overall quality of life. Some studies show positive outcomes in 60-80% of patients.”<\/p>\n
Success is often measured by improvements in standardized scales that assess motor skills, balance, speech, and activities of daily living. Many patients report being able to walk again, regaining use of their limbs, and experiencing clearer speech after treatment.<\/p>\n
It is important to have realistic expectations. Stem cell therapy is not a cure for a stroke, but rather a powerful tool to enhance the body’s natural recovery processes. The best results are often seen in patients who are committed to a comprehensive rehabilitation program alongside the stem cell therapy.<\/p>\n
<\/span>How soon after a stroke can a patient receive stem cell therapy?<\/strong><\/span><\/h2>\n“The optimal timing for stem cell therapy after a stroke is a subject of ongoing research, but many clinics recommend treatment within the first few months to a year after the stroke. However, studies have shown that even patients who receive therapy years after their stroke can still experience significant benefits.”<\/p>\n
The subacute phase (from a few days to several months after the stroke) is often considered an ideal window for intervention, as the brain is in a heightened state of plasticity and repair. However, the regenerative and anti-inflammatory properties of stem cells can be beneficial even in the chronic phase.<\/p>\n
The decision on timing should be made in consultation with the medical team at the Colombian clinic, who will assess the individual patient’s case and recommend the most appropriate course of action.<\/p>\n